References
- Yonehara S., Ishii A., Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 1989; 169: 1747–1756
- Itoh N., Yonehara S., Ishii A., Yonehara M., Mizushima S., Sameshima M., Hase A., Seto Y., Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66: 233–243
- Trauth B. C., Klas C., Peters A. M. J., Matzku S., Moeller P., Falk W., Debatin K. M., Krammer P. H. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989; 245: 301–305
- Suda T., Takahashi T., Golstein P., Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75: 1169–1178
- Takahashi T., Tanaka M., Inazawa J., Abe T., Suda T., Nagata S. Human Fas ligand: Gene structure, chromosome location and species specificity. Int. Immunol. 1994; 6: 1567–1574
- Watanabe-Fukunaga R., Brannan C. L, Copeland N. G., Jenkins N. A., Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356: 314–317
- Robertson M. J., Manley T. J., Pichert G., Cameron C., Cochran K. J., Levine H., Ritz J. Functional consequences of Apo-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells. Leuk. Lymphoma 1995; 17: 51–61
- Kodama Y., Zhou Y. W., Zhang X. L., Xue H. L., Sakai H., Tanaka S., Sakatoku H., Sakurai M. Fas receptor (CD95)-mediated apoptosis is induced in leukemic cells entering GIB compartment of the cell cycle. Blood 1995; 86: 3848–3860
- Shima Y., Nishimoto N., Ogata A., Fujii Y., Yoshizaki K., Kishimoto T. Myeloma cells express Fas antigen/Apo-1 (CD95) but only some are sensitive to anti-Fas anti-body resulting in apoptosis. Blood 1995; 85: 757–764
- Westendorf J. J., Lammert J. M., Jelinek D. F. Expression and function of Fas (Apo-1/CD95) in patient myeloma cells and myeloma cell lines. Blood 1995; 85: 3566–3576
- Hata H., Matsuzaki H., Takeya M., Yoshida M., Sonoki T., Nagasaki A., Kuribayashi N., Kawano F., Takatsuki K. Expression of Fas/Apo-1 (CD95) and apoptosis in tumor cells from patients with plasma cell disorders. Blood 1995; 86: 1939–1945
- Matsuzaki H., Hata H., Takeya M., Takatsuki K. Establishment and characterization of an amylase-producing human myeloma cell line. Blood 1988; 72: 978–982
- Hata H., Matsuzaki H., Sonoki T., Takemoto S., Kuribayashi N., Nagasaki A., Takatsuki K. Establishment of a CD95-positive immature plasma cell line from an aggressive myeloma with high serum lactate dehydrogenase. Leukemia 1994; 8: 1768–1773
- Ohtsuki T., Yawata Y., Wada H., Sugihara T., Mori M., Namba M. Two human myeloma cell lines. amylase-producing KMS-12-PE and amylase-non-producing KMS-12-BM, were established from a patient, having the same chromosome marker, t(11;14)(q13;q32). Br. J. Haematol. 1989; 73: 199–204
- Barlogie B., Smallwood L., Smith T., Alexanian L. High serum levels of lactic dehydrogenase identify a high grade lymphoma-like myeloma. Ann. Int. Med. 1989; 110: 521–525
- Leoncini L., Vecchio M. T. D., Megha T., Barbini P., Galieni P., Pileri S., Sabattini E., Gherlinzoni F., Tosi P., Kraft R., Cottier H. Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas. Am. J. Pathol. 1993; 142: 755–763
- Vacca A., Loreto M. D., Ribatti D., Stefano R. D., Gadaleta-Caldarola G., Iodice G., Caloro D., Dammacco F. Bone marrow of patients with active multiple myeloma: Angiogenesis and plasma cell adhesion molecules LFA-1, VLA-4, LAM-1, and CD44. Am. J. Hematol. 1995; 50: 9–14
- Facchinetti A., Tessarollo L., Mazzocchi M., Kingston R., Collavo D., Biasi G. An improved method for the detection of DNA fragmentation. J. Immunol. Methods 1991; 136: 125–131
- Lacronique V., Mignon A., Fabre M., Viollet B., Rouquet N., Molina T., Porteu A., Henrion A., Bouscary D., Varlet P., Joulin V., Kahn A. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nature Med. 1996; 2: 80–86
- Iwai K., Miyawaki T., Takizawa T., Konno A., Ohta K., Yachie A., Seki H., Taniguchi N. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood 1994; 84: 1201–1208
- Debatin K. M., Krammer P. H. Resistance to Apo-1 (CD95) induced apoptosis in T-ALL is determined by a bcl-2 independent anti-apoptotic program. Leukemia 1995; 9: 815–820